InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Schweizer Errol, Director. Director active across 1 company, notably MedMen Enterprises, Inc.. Aggregated, 3 disclosures have been logged. Activity tracked since 27 August 2021. The latest transaction was filed on 19 April 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Errol Schweizer is a Board Member of MedMen Enterprises, Inc. He contributes to the governance of the company and the development of its strategy in the cannabis sector.